About Joint Academy
Become the global standard treatment for osteoarthritis
We are a healthcare company with a focus on science and technology. The digital osteoarthritis treatment Joint Academy combines physical activity, education, and healthcare professionals that are always on hand. With this kind of digital treatment method, healthcare becomes both more scalable and more efficient.
Joint Academy’s treatment is based on published, scientific studies and extensive experience from specialists in osteoarthritis, which shows in our patients’ results.
The meeting of digital treatment and data science opens up new possibilities of treating chronic conditions in a sustainable, available, and more personal way.
We who work at Joint Academy are never more than a click or call away - no matter if you’re a patient or partner - and we always do our best to help.
We stand behind the company
Joint Academy AB was founded by father and son, Leif and Jakob Dahlberg, in 2014. At the time, Jakob studied Computer Science while Leif continued his leading research on osteoarthritis. Jakob saw an opportunity to scale up his father’s research to a global level with the help of software. He then started putting the puzzle, that was to become Joint Academy, together.
Today, the team at Joint Academy consists of more than 40 people with various backgrounds that all work to make the world’s first successful digital osteoarthritis treatment available for millions of people and, with that, improve lives all over the world.
World-leading medical competence
Leif Dahlberg, Chief Medical Officer
Leif Dahlberg is a professor in orthopedics and has more than 25 years of experience of research in cartilage and joints. His current research involves the cartilage on a molecular level, MRI, and clinical work focused on epidemiology. Dahlberg has published more than 100 peer-reviewed scientific studies and has been cited close to 3000 times.
Stefan Lohmander, Professor, MD, PhD
Stefan Lohmander, MD and PhD, is an international expert based at Lund University. The areas Lohmander has focused on has been to understand relevant ways of observing the progression of osteoarthritis as well as the causations of the condition. Lohmander’s lifelong commitment has always been centered around improving osteoarthritis treatment while also improving the single individual’s quality of life.